[Lecture Report] The 8th NIKKEI FT Communicable Diseases Conference – Never to Repeat the Crisis: Renewal of Our Commitment for Fighting against Communicable Diseases – (The NIKKEI, October 27-28, 2021, Chiyoda-ku, Tokyo)
date : 11/10/2021
Tags: AMR
![[Lecture Report] The 8th NIKKEI FT Communicable Diseases Conference – Never to Repeat the Crisis: Renewal of Our Commitment for Fighting against Communicable Diseases – (The NIKKEI, October 27-28, 2021, Chiyoda-ku, Tokyo)](https://hgpi.org/en/wp-content/uploads/sites/2/lecture-media-161-top2-1.jpg)
On October 27 and 28, 2021, HGPI Chairman Dr. Kiyoshi Kurokawa and HGPI CEO and Board Member Mr. Ryoji Noritake spoke at various programs throughout both days of the 8th NIKKEI FT Communicable Diseases Conference, which was entitled “Never to Repeat the Crisis: Renewal of Our Commitment for Fighting against Communicable Diseases.” The event was co-hosted by the NIKKEI, the Financial Times and Tokyo Metropolitan Government.
For details, please visit the event website, which can be found here.
Below is an excerpt from the program that included Dr. Kurokawa and Mr. Noritake. The full speaker list can be viewed here.
October 27 (Wed.)
Special Session 1: Effectiveness of Antigen testing in the prevention of COVID-19 infectious diseases
Discusser: Kiyoshi Kurokawa (HGPI Chairman)
Special Session 2: Collaboration among Stakeholders to Implement the “Strategy for Strengthening Vaccine Development and Production Systems”
Moderator: Ryoji Noritake (HGPI Board Member and CEO)
Special Agenda: How International Consortium Accelerates Drug Development for COVID-19
Discusser: Kiyoshi Kurokawa
October 28 (Thu.)
Agenda 7 – Key discussion issue 6: Nation’s decision making
Discusser: Ryoji Noritake
Special Session 5: Urgent need for measures against AMR threat as silent pandemics
Moderator: Ryoji Noritake
Breakout Session E: The economic value of AMR countermeasures and the need for new antimicrobials
Moderator: Ryoji Noritake
Agenda 8 – PPP projects from the Conference and their future issues
Moderator: Ryoji Noritake
Summary Session
Discusser: Ryoji Noritake
Conclusion/Statement
Discusser: Ryoji Noritake
Top Research & Recommendations Posts
- [Public Comment Submission] “Basic Plan for the Promotion of Cancer Control (Draft)” (February 18, 2023)
- [Urgent Recommendations] Challenges and Prospects for the Implementation and Execution of the Basic Law and Basic Policy for Child and Maternal Health and Development (February 17, 2023)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Publication Report] The Children’s Health Project Publishes Family Mental Health Booklet “Nurturing Child and Guardian Mental Health through Our Communication with Children” in Five Languages (February 6, 2023)
- [Research Report] 2019 Survey on Healthcare in Japan
Featured Posts
-
2022-12-26
[Event Report] The Health and Global Policy Institute Chronic Disease Control Project Holds Advisory Board Meeting for “Engaging and Cooperating with Patients, Citizens, and Communities for Obesity Prevention” (September 22, 2022)
-
2023-03-06
[In the Media] What Healthy Climate Prescription Teaches Us: Health Care’s Approach to the Climate Crisis (Min-Iren Iryo, No. 606; February 24, 2023)
-
2023-03-09
[Event Report] HGPI Special Seminar – Universal Health Coverage in an Era of Antimicrobial Resistance (August 18, 2022)
-
2023-03-15
[Event Report] The Cardiovascular Disease Control Promotion Project, Phase 2. “Current Issues and Prospects for Advancing Cardiovascular Disease Control Promotion Plans in Each Prefecture” (March 15, 2023)